Researchers make breakthrough in fighting a leading cause of fungal pneumonia medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring to phase one clinical trial a nasal spray vaccine university researchers invented to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of pneumonia.
New Orleans colleges are investing in corporate partnerships and internships, academic programs and research efforts to continue to fuel pipelines of college students into various workforce industries.